TNYA
Tenaya TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
TNYA vs peer average
87/100
TNYA vs. peer average (B vs. D)
Grade spread
B 2 · D 1 · F 7
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
RCKT is the first available peer comparator.
Rocket Pharmaceuticals is one of the only direct public operating comparators Tenaya itself names for TN-401; the prior packet baseline cites the 2026 10-K as identifying Rocket’s RP-A601 as principal competition for PKP2-associated ARVC, making Rocket a relevant but narrow read-through on gene-therapy execution rather than a broad company-wide peer [#10-K-2026-03-11].
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TNYA
Tenaya Therapeutics
RCKT
Rocket
Grade
B
B
Momentum
92
56
Value
41
41
Sentiment
74
72
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs RCKT
TNYA / RCKT
Grade Position
Above peers
TNYA vs. peer average (B vs. D)
87/100
Momentum
92
TNYAValue
41
TNYASentiment
74
TNYARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TNYA
RCKT is the first peer returned for this comparison set.